Viemed Healthcare, Inc. (NASDAQ:VMD – Get Free Report) insider William Frazier sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $11.72, for a total value of $117,200.00. Following the completion of the sale, the insider directly owned 73,214 shares in the company, valued at approximately $858,068.08. This represents a 12.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Viemed Healthcare Stock Down 0.5%
VMD stock traded down $0.06 on Friday, reaching $11.63. 882,599 shares of the company traded hands, compared to its average volume of 260,443. Viemed Healthcare, Inc. has a one year low of $5.93 and a one year high of $11.88. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.22 and a quick ratio of 1.10. The company has a market cap of $445.89 million, a P/E ratio of 31.43 and a beta of 1.12. The firm has a fifty day simple moving average of $9.87 and a 200-day simple moving average of $8.82.
Viemed Healthcare (NASDAQ:VMD – Get Free Report) last released its earnings results on Tuesday, May 5th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.03). Viemed Healthcare had a return on equity of 10.52% and a net margin of 5.20%.The company had revenue of $75.41 million during the quarter, compared to the consensus estimate of $74.40 million. Research analysts anticipate that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current year.
Institutional Trading of Viemed Healthcare
About Viemed Healthcare
Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.
Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.
See Also
- Five stocks we like better than Viemed Healthcare
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
